Domov › Rakovina prsníka › Michigan › Grand Rapids
Klinické štúdie Rakovina prsníka v meste Grand Rapids, MI
26 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Grand Rapids a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- START - Midwest, Grand Rapids
A Study of PHST001 in Advanced Solid Tumors
Prebieha náborFáza 1
- START Center for Cancer Research - Midwest, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Prebieha nábor
- Cancer & Hematology Centers, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Prebieha náborFáza 1
- BAMF Health Inc., Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Prebieha náborFáza 1
- BAMF Health Inc., Grand Rapids
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Prebieha náborFáza 1/2
- START Midwest, LLC, Grand Rapids
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Prebieha náborFáza 3
- The Cancer & Hematology Centers, Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Prebieha náborFáza 1
- START - Midwest Cancer Research Center, Grand Rapids
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Prebieha náborFáza 1
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Prebieha náborFáza 3
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Prebieha náborFáza 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- START Midwest, Grand Rapids
E-Mindfulness Approaches for Living After Breast Cancer
Prebieha náborFáza 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Prebieha náborFáza 1/2
- START Midwest, Grand Rapids
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Prebieha náborFáza 1
- BAMF Health, Grand Rapids
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- START Midwest, LLC, Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- START Midwest, Grand Rapids
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Prebieha náborFáza 2
- GSK Investigational Site, Grand Rapids
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Prebieha náborFáza 3
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Prebieha náborFáza 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Prebieha náborFáza 1/2
- START, Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Prebieha náborFáza 1/2
- START Midwest, Grand Rapids
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Prebieha náborFáza 3
- Spectrum Health at Butterworth Campus, Grand Rapids
Štúdie Rakovina prsníka v iných mestách
- New York City, NY136 štúdií
- Houston, TX126 štúdií
- Boston, MA112 štúdií
- Nashville, TN81 štúdií
- Los Angeles, CA73 štúdií
- Edison, NJ68 štúdií
- St. Louis, MO64 štúdií
- Queens, NY64 štúdií
- Durham, NC64 štúdií
- Chicago, IL59 štúdií
- Philadelphia, PA56 štúdií
- Dallas, TX55 štúdií
Iné štúdie v Grand Rapids
- Nemalobunkový karcinóm pľúc44 štúdií
- Kolorektálny karcinóm40 štúdií
- Rakovina (všetky typy)28 štúdií
- Rakovina vaječníkov24 štúdií
- Metastatická rakovina22 štúdií
- Rakovina prostaty19 štúdií
- Rakovina endometria18 štúdií
- Rakovina žalúdka18 štúdií
- Rakovina pankreasu18 štúdií
- Melanóm17 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku15 štúdií
- Trojnásobne negatívny karcinóm prsníka15 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.